A detailed history of May Hill Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, May Hill Capital, LLC holds 1,317 shares of AMGN stock, worth $368,839. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,317
Previous 1,255 4.94%
Holding current value
$368,839
Previous $327 Million 25.44%
% of portfolio
0.15%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 30, 2025

BUY
$258.59 - $327.36 $16,032 - $20,296
62 Added 4.94%
1,317 $410 Million
Q4 2024

Feb 12, 2025

BUY
$258.78 - $328.31 $324,768 - $412,029
1,255 New
1,255 $327 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track May Hill Capital, LLC Portfolio

Follow May Hill Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of May Hill Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on May Hill Capital, LLC with notifications on news.